RxDoctor Payments Data

Nina Yoshpe, MD

Otolaryngology · Long Beach, CANPI 1952475691

Payments from drug & device makers

$11,132in general payments, 2019–2025

Across 224 payments — averaging $49.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$1K
  • Integra Lifesciences Corporation$1K
  • GSK$1K
  • Sanofi$1K
  • Regeneron Healthcare Solutions, Inc.$874
  • Aerin Medical Inc.$738
  • plus $5K from 21 others

What the payments were for

  • Travel & lodging$2,30521%
  • Food & beverage$8,53777%
  • Education$2903%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,132 in reported general payments places this provider in the 90th percentile of 1,021 otolaryngology providers in California.

See all otolaryngology providers in California

Medicare billing

Part B allowed, 2024
$151,760
Medicare patients
525
Services billed
1,828

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Famotidine207$1,648
Fluticasone Propionate107$1,570
Ipratropium Bromide33$1,417
Azelastine Hcl27$731
Montelukast Sodium35$334
Mupirocin33$238
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav27$179
Omeprazole14$147
Azithromycin22$75
Methylprednisolone16$66

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Long Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →